An α‐E‐catenin (CTNNA1) mutation in hereditary diffuse gastric cancer

Citations Over TimeTop 10% of 2012 papers

Abstract

Diffuse gastric cancers typically present as late-stage tumours and, as a result, the 5 year survival rate is poor. Some gastric cancers are hereditary and these tend to be of the diffuse type; 30-40% of hereditary diffuse gastric cancers (HDGCs) can be explained by defective germline alleles of E-cadherin (CDH1), but for the remaining families the factors driving susceptibility remain unknown. We had access to a large HDGC pedigree with no obvious mutation in CDH1, and applied exome sequencing to identify new genes involved in gastric cancer. We identified a germline truncating allele of α-E-catenin (CTNNA1) that was present in two family members with invasive diffuse gastric cancer and four in which intramucosal signet ring cells were detected as part of endoscopic surveillance. The remaining CTNNA1 allele was silenced in the two diffuse gastric cancers from the family that were available for screening, and this was also true for signet ring cells identified in endoscopic biopsies. Since α-E-catenin functions in the same complex as E-cadherin, our results call attention to the broader signalling network surrounding these proteins in HDGC. We also detected somatic mutations in one tumour and found substantial overlap with genes mutated in sporadic gastric cancer, including PIK3CA, ARID1A, MED12 and MED23.

Related Papers

• → Beyond E-cadherin: roles of other cadherin superfamily members in cancer(2014)466 cited
• → E‐cadherin's role in development, tissue homeostasis and disease: Insights from mouse models(2014)61 cited
• → E-cadherin to P-cadherin switching in lobular breast cancer with tubular elements(2020)44 cited
• → Is Upregulation of BCL2 a Determinant of Tumor Development Driven by Inactivation of CDH1/E-Cadherin?(2013)9 cited
• Disordered beta-catenin expression and E-cadherin/CDH1 promoter methylation in gastric carcinoma(2006)